We use cookies to provide you with a better experience. By continuing to browse the site you are agreeing to our use of cookies in accordance with our Cookie Policy.
Accept
Home » Aussie Guidance Details Nonclinical Requirements for Drug Registration
Aussie Guidance Details Nonclinical Requirements for Drug Registration
Drugmakers seeking to list their products on the Australian Register of Therapeutic Goods should include unfavorable nonclinical study reports in their applications, updated guidance says.
To View This Article:
Login
Subscribe To International Pharmaceutical Regulatory Monitor